tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Caufield, 102 are a BUY (85.71%), 17 are a HOLD (14.29%).
Analyst Matthew Caufield, carries an average stock price target met ratio of 29.63% that have a potential upside of 27.08% achieved within 67 days. Previously, Matthew Caufield worked at HC WAINWRIGHT.
Matthew Caufield’s has documented 222 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ADVM, Adverum Biotechnologies at 22-Sep-2025.
Analyst best performing recommendations are on MLYS (MINERALYS THERAPEUTICS, COMMON STOCK).
The best stock recommendation documented was for MLYS (MINERALYS THERAPEUTICS, COMMON STOCK) at 8/13/2025. The price target of $42 was fulfilled within 58 days with a profit of $28.44 (209.73%) receiving and performance score of 36.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$10
$4.76 (90.84%)
5 months 12 days ago
(18-May-2025)
0/11 (0%)
$7.58 (313.22%)
Buy
$6
$0.76 (14.50%)
$24
6 months 27 days ago
(03-Apr-2025)
0/3 (0%)
$4.11 (217.46%)
Buy
$10
$4.76 (90.84%)
1 years 2 months 23 days ago
(07-Aug-2024)
0/1 (0%)
$5.81 (138.66%)
Buy
$8
$2.76 (52.67%)
$25
2 years 14 days ago
(16-Oct-2023)
0/10 (0%)
$6.16 (334.78%)
Hold
$14
2 years 14 days ago
(16-Oct-2023)
2/3 (66.67%)
$6.42 (84.70%)
362
Which stock is Matthew Caufield is most bullish on?
Which stock is Matthew Caufield is most reserved on?
What Year was the first public recommendation made by Matthew Caufield?
